Eurand (Vandalia, Ohio) Receives Approval To Market Generic Sodium Diclofenac

MILAN, Italy, Oct. 25 /PRNewswire/ -- Eurand today announced that it has received final approval from the Medicines and Healthcare Regulatory Agency (MHRA) in the United Kingdom (UK) for its Application for Sodium Diclofenac 75mg and 100mg modified release capsules. Sodium Diclofenac modified release is the generic version of Voltarol(R), a Novartis product. Sodium Diclofenac is used to treat all levels of pain and inflammation in a wide variety of conditions. The market for sodium Diclofenac in the UK is approximately Stg 90 million ($130M). The approved product will be marketed in the UK by Sandoz (UK).

The product utilizes Eurand's Diffucaps(R) technology and will be produced at Eurand's manufacturing facility in Milan, Italy. The product is available for licencing in other countries.

"This product was developed by Eurand and is the thirteenth Eurand product to be marketed in the UK. This approval is another example of Eurand's strategy to create a balanced product portfolio by registering and selling our products in the major markets of the world" said Gearoid Faherty, CEO of Eurand.

About Eurand

Eurand is a privately held specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug delivery technologies. The Company specializes in bioavailability enhancement of poorly soluble drugs, modified release, taste masking and drug conjugation.

Eurand is currently developing a pipeline of products based on its proprietary drug delivery technologies. The company also works with many of the world's leading pharmaceutical and biotechnology companies to develop enhanced forms of their existing products and development compounds. In the last four years, Eurand has had two partner products and one Eurand product approved by the FDA and had revenues of over $100 million in 2003.

Eurand's principal operating offices are in Milan, Italy while its US business is directed from Eurand, Inc. in Vandalia, Ohio. The Company has research, development and manufacturing facilities in Italy and the United States and an additional manufacturing facility in France.

Eurand has partnered with Warburg Pincus, one of the worlds leading private equity firms.

Eurand

CONTACT: Gearoid Faherty, CEO of Eurand (Italy), +39-02-954281, orbizdev@eurand.com

Back to news